WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HRTX

Based on 1 analyst offering 12 month price targets for Heron Therapeutics Inc

Min Forecast
$4.00+117.39%
Avg Forecast
$4.00+117.39%
Max Forecast
$4.00+117.39%

Should I buy or sell HRTX stock?

Based on 1 analyst offering ratings for Heron Therapeutics Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their HRTX stock forecasts and price targets.

HRTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-11

1 of 1

Forecast return on equity

Is HRTX forecast to generate an efficient return?

Company
-144.86%
Industry
147.71%
Market
81.76%
HRTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HRTX forecast to generate an efficient return on assets?

Company
20.91%
Industry
35.52%
HRTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HRTX earnings per share forecast

What is HRTX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.03
Avg 2 year Forecast
$0.08
Avg 3 year Forecast
$0.20

HRTX revenue forecast

What is HRTX's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$158.5M+9.85%
Avg 2 year Forecast
$188.4M+30.57%
Avg 3 year Forecast
$213.8M+48.18%
HRTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HRTX revenue growth forecast

How is HRTX forecast to perform vs Biotechnology companies and vs the US market?

Company
14.15%
Industry
65.42%
Market
10.4%
HRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HRTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HRTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
HRTX$1.84$4.00+117.39%Buy
PHAT$4.03$22.00+445.91%Buy
GLUE$4.55$13.50+196.70%Buy
ATYR$3.10$25.50+722.58%Buy
ARCT$10.53$54.75+419.94%Strong Buy
View Top Biotech Stocks

Heron Therapeutics Stock Forecast FAQ

Is Heron Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HRTX) stock is to Buy HRTX stock.

Out of 1 analyst, 0 (0%) are recommending HRTX as a Strong Buy, 1 (100%) are recommending HRTX as a Buy, 0 (0%) are recommending HRTX as a Hold, 0 (0%) are recommending HRTX as a Sell, and 0 (0%) are recommending HRTX as a Strong Sell.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.

What is HRTX's earnings growth forecast for 2025-2027?

(NASDAQ: HRTX) Heron Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.2%.

Heron Therapeutics's earnings in 2025 is -$13,580,000.On average, 2 Wall Street analysts forecast HRTX's earnings for 2025 to be -$3,808,240, with the lowest HRTX earnings forecast at -$7,616,479, and the highest HRTX earnings forecast at $0. On average, 1 Wall Street analyst forecast HRTX's earnings for 2026 to be $12,186,367, with the lowest HRTX earnings forecast at $12,186,367, and the highest HRTX earnings forecast at $12,186,367.

In 2027, HRTX is forecast to generate $30,465,918 in earnings, with the lowest earnings forecast at $30,465,918 and the highest earnings forecast at $30,465,918.

What is HRTX's revenue growth forecast for 2025-2027?

(NASDAQ: HRTX) Heron Therapeutics's forecast annual revenue growth rate of 14.15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.42%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.4%.

Heron Therapeutics's revenue in 2025 is $144,285,000.On average, 2 Wall Street analysts forecast HRTX's revenue for 2025 to be $24,144,239,698, with the lowest HRTX revenue forecast at $23,611,086,140, and the highest HRTX revenue forecast at $24,677,393,256. On average, 1 Wall Street analysts forecast HRTX's revenue for 2026 to be $28,698,894,379, with the lowest HRTX revenue forecast at $28,698,894,379, and the highest HRTX revenue forecast at $28,698,894,379.

In 2027, HRTX is forecast to generate $32,568,065,914 in revenue, with the lowest revenue forecast at $32,568,065,914 and the highest revenue forecast at $32,568,065,914.

What is HRTX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: HRTX) forecast ROA is 20.91%, which is lower than the forecast US Biotechnology industry average of 35.52%.

What is HRTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HRTX price target, the average HRTX price target is $4.00, with the highest HRTX stock price forecast at $4.00 and the lowest HRTX stock price forecast at $4.00.

The Wall Street analyst predicted that Heron Therapeutics's share price could reach $4.00 by Apr 11, 2026. The average Heron Therapeutics stock price prediction forecasts a potential upside of 117.39% from the current HRTX share price of $1.84.

What is HRTX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: HRTX) Heron Therapeutics's current Earnings Per Share (EPS) is -$0.09. On average, analysts forecast that HRTX's EPS will be -$0.03 for 2025, with the lowest EPS forecast at -$0.05, and the highest EPS forecast at $0.00. On average, analysts forecast that HRTX's EPS will be $0.08 for 2026, with the lowest EPS forecast at $0.08, and the highest EPS forecast at $0.08. In 2027, HRTX's EPS is forecast to hit $0.20 (min: $0.20, max: $0.20).

What is HRTX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: HRTX) forecast ROE is -144.86%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.